| Leonard Braden Michael |
Non-Executive |
Adverum Biotechnologies, Inc. (ADVM)
|
2025-04-02 |
$4.23 |
0.0% |
34,775
|
$147,076 |
| Leonard Braden Michael |
Non-Executive |
Adverum Biotechnologies, Inc. (ADVM)
|
2025-03-27 |
$5.11 |
0.0% |
37,000
|
$188,931 |
| Leonard Braden Michael |
Non-Executive |
Adverum Biotechnologies, Inc. (ADVM)
|
2025-03-20 |
$4.98 |
0.0% |
117,941
|
$587,575 |
| Leonard Braden Michael |
Non-Executive |
Adverum Biotechnologies, Inc. (ADVM)
|
2025-02-28 |
$4.27 |
0.0% |
336,756
|
$1,439,087 |
| Leonard Braden Michael |
Non-Executive |
Reneo Pharmaceuticals, Inc. (RPHM)
|
2024-09-25 |
$14.72 |
-90.0% |
9,835
|
$144,738 |
| Leonard Braden Michael |
Non-Executive |
Reneo Pharmaceuticals, Inc. (RPHM)
|
2024-09-18 |
$13.59 |
-90.0% |
5,611
|
$76,237 |
| Leonard Braden Michael |
Non-Executive |
Reneo Pharmaceuticals, Inc. (RPHM)
|
2024-09-16 |
$13.49 |
-90.0% |
35,892
|
$484,344 |
| Leonard Braden Michael |
Non-Executive |
Talis Biomedical Corp (TLIS)
|
2024-09-06 |
$1.47 |
0.0% |
30,100
|
$44,240 |
| Leonard Braden Michael |
Non-Executive |
Talis Biomedical Corp (TLIS)
|
2024-09-03 |
$4.00 |
0.0% |
500
|
$2,000 |
| Leonard Braden Michael |
Non-Executive |
Talis Biomedical Corp (TLIS)
|
2024-08-30 |
$4.25 |
-67.8% |
151
|
$642 |
| Leonard Braden Michael |
Non-Executive |
Talis Biomedical Corp (TLIS)
|
2024-08-28 |
$3.90 |
-64.9% |
14,382
|
$56,137 |
| Leonard Braden Michael |
Non-Executive |
AN2 Therapeutics, Inc. (ANTX)
|
2024-08-14 |
$1.04 |
-1.0% |
1,500,000
|
$1,560,000 |
| Leonard Braden Michael |
Non-Executive |
Reneo Pharmaceuticals, Inc. (RPHM)
|
2024-08-14 |
$14.00 |
-89.8% |
27,183
|
$380,598 |
| Leonard Braden Michael |
Non-Executive |
Aclaris Therapeutics, Inc. (ACRS)
|
2024-08-05 |
$1.27 |
-6.8% |
373,569
|
$472,757 |
| Leonard Braden Michael |
Non-Executive |
Aclaris Therapeutics, Inc. (ACRS)
|
2024-07-31 |
$1.31 |
-10.0% |
273,730
|
$359,010 |
| Leonard Braden Michael |
Non-Executive |
Adverum Biotechnologies, Inc. (ADVM)
|
2024-07-30 |
$7.15 |
-4.6% |
85,800
|
$613,470 |
| Leonard Braden Michael |
Non-Executive |
Aclaris Therapeutics, Inc. (ACRS)
|
2024-07-22 |
$1.30 |
-9.5% |
154,722
|
$201,808 |
| Leonard Braden Michael |
Non-Executive |
Adverum Biotechnologies, Inc. (ADVM)
|
2024-07-18 |
$8.26 |
-17.4% |
216,264
|
$1,785,662 |
| Leonard Braden Michael |
Non-Executive |
Aclaris Therapeutics, Inc. (ACRS)
|
2024-07-05 |
$1.15 |
2.4% |
352,397
|
$405,894 |
| Leonard Braden Michael |
Non-Executive |
Aclaris Therapeutics, Inc. (ACRS)
|
2024-07-01 |
$1.13 |
4.5% |
1,543,434
|
$1,742,075 |
| Leonard Braden Michael |
Non-Executive |
Aclaris Therapeutics, Inc. (ACRS)
|
2024-06-18 |
$1.15 |
2.4% |
545,000
|
$628,206 |
| Leonard Braden Michael |
Non-Executive |
Aclaris Therapeutics, Inc. (ACRS)
|
2024-06-13 |
$1.11 |
6.7% |
1,611,200
|
$1,781,897 |
| Leonard Braden Michael |
Non-Executive |
AVROBIO, Inc. (AVRO)
|
2024-05-14 |
$15.21 |
-90.8% |
63,886
|
$971,493 |
| Leonard Braden Michael |
Non-Executive |
Reneo Pharmaceuticals, Inc. (RPHM)
|
2024-05-14 |
$15.44 |
-90.7% |
41,428
|
$639,578 |
| Leonard Braden Michael |
Non-Executive |
Cyteir Therapeutics, Inc. (CYT)
|
2024-03-20 |
$2.95 |
2.0% |
170,589
|
$503,238 |
| Leonard Braden Michael |
Non-Executive |
Cyteir Therapeutics, Inc. (CYT)
|
2024-03-18 |
$3.01 |
0.0% |
113,777
|
$342,469 |
| Leonard Braden Michael |
Non-Executive |
Metacrine, Inc. (MTCR)
|
2022-12-21 |
$0.40 |
46.8% |
271,605
|
$107,594 |
| Leonard Braden Michael |
Non-Executive |
ASTROTECH Corp (ASTC)
|
2022-12-02 |
$10.31 |
-1.6% |
6,366
|
$65,599 |
| Leonard Braden Michael |
Non-Executive |
Satsuma Pharmaceuticals, Inc. (STSA)
|
2022-11-21 |
$0.71 |
54.6% |
150,000
|
$106,740 |
| Leonard Braden Michael |
Non-Executive |
ASTROTECH Corp (ASTC)
|
2022-11-18 |
$11.14 |
-8.9% |
13,016
|
$144,940 |
| Leonard Braden Michael |
Non-Executive |
Satsuma Pharmaceuticals, Inc. (STSA)
|
2022-11-15 |
$0.68 |
61.2% |
6,440,000
|
$4,394,273 |
| Leonard Braden Michael |
Non-Executive |
Metacrine, Inc. (MTCR)
|
2022-11-09 |
$0.41 |
40.3% |
164,270
|
$68,074 |
| Leonard Braden Michael |
Non-Executive |
Metacrine, Inc. (MTCR)
|
2022-10-28 |
$0.39 |
48.9% |
812,529
|
$317,328 |
| Leonard Braden Michael |
Non-Executive |
Metacrine, Inc. (MTCR)
|
2022-10-26 |
$0.35 |
65.6% |
1,262,166
|
$443,100 |
| Leonard Braden Michael |
Non-Executive |
ASTROTECH Corp (ASTC)
|
2022-10-18 |
$11.34 |
-10.6% |
7,214
|
$81,838 |
| Leonard Braden Michael |
Non-Executive |
ASTROTECH Corp (ASTC)
|
2022-09-27 |
$13.13 |
-22.7% |
11,931
|
$156,608 |
| Leonard Braden Michael |
Non-Executive |
ASTROTECH Corp (ASTC)
|
2022-09-02 |
$13.96 |
-27.4% |
8,402
|
$117,304 |
| Leonard Braden Michael |
Non-Executive |
ASTROTECH Corp (ASTC)
|
2022-08-24 |
$13.70 |
-26.0% |
15,977
|
$218,899 |
| Leonard Braden Michael |
Non-Executive |
RETRACTABLE TECHNOLOGIES INC (RVP)
|
2022-05-25 |
$3.98 |
-77.1% |
63,474
|
$252,898 |
| Leonard Braden Michael |
Non-Executive |
RETRACTABLE TECHNOLOGIES INC (RVP)
|
2022-05-19 |
$3.82 |
-76.1% |
140,056
|
$534,857 |
| Leonard Braden Michael |
Non-Executive |
RETRACTABLE TECHNOLOGIES INC (RVP)
|
2022-05-16 |
$3.96 |
-76.9% |
139,881
|
$553,721 |
| Leonard Braden Michael |
Non-Executive |
RETRACTABLE TECHNOLOGIES INC (RVP)
|
2022-05-11 |
$3.83 |
-76.1% |
73,464
|
$281,044 |
| Leonard Braden Michael |
Non-Executive |
RETRACTABLE TECHNOLOGIES INC (RVP)
|
2022-05-02 |
$3.73 |
-75.5% |
430,000
|
$1,603,219 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-8.0% |
$-2,010,925 |
$25,007,195 |